Background: There are insufficient data regarding how to deal with moderate aortic valve (AV) dysfunction during rheumatic mitral valve (MV) surgery. In this study, the clinical outcomes of patients ...

Background: Crohn's Disease (CD) commonly presents extra-intestinal manifestations, but cardiac involvement is considered rare. The aim of the present study was to assess cardiac involvement in CD ...

This study evaluated the prognostic value of a novel echocardiographic cardiac damage classification system for patients with moderate or severe AFMR. Methods In a retrospective multicentre study, ...

1 Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA 2 Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA Objective Discrepancy in the ...

The current study demonstrates that LV mass and replacement myocardial fibrosis on CMR were independently associated with echocardiographic LV GLS; while CMR measures of reactive interstitial fibrosis ...

For the first time, researchers said SGLT2 inhibitors may have some disease-modifying potential for nonsevere aortic stenosis ...

Faculty of Medicine, University of Queensland (A.K.C.L., A.N., J.M., S.P., J.J.A.). Cardiology Department, Royal Brisbane and Women’s Hospital, Queensland ...

A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...

The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

The apparent benefits at 2 years observed in the nonrandomized ALT-FLOW study pave the way for a sham-controlled trial.

Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...